We validated 22 of 41 known histological DN or BC markers at the transcriptional level (for example, for DNs: increased expression of NEFH and SLC32A1 and decreased expression of SLK; for BCs: increased expression of VIM, CRYAB and GPNMB) (Extended Data Fig. 8a). This evidence concerns the gene VIM and breast cancer.